One of the more frustrating conversations in medicine goes like this. A woman in her forties describes months of broken sleep, flattened energy, irregular cycles, mood changes she does not recognize in herself, and weight that will not move. Her bloodwork comes back unremarkable. She is told her labs are normal, and the conversation ends there.
The labs may well be normal. That does not mean nothing is happening, and it does not mean the right tests were ordered.
Perimenopause is a transition, not an event. It can begin in the early forties and run a decade or longer, and during it ovarian function declines unevenly. Estrogen, progesterone, and testosterone fluctuate substantially, sometimes week to week.
A single measurement of FSH or estradiol captures one point on a moving curve. Drawn on a different day, the same patient can produce a meaningfully different result. This is why interpreting one value in isolation is unreliable, and why we prefer repeated measurements read alongside symptoms and cycle history rather than a single number treated as a verdict.
Hormones. FSH, estradiol, progesterone, and total and free testosterone, ideally tracked over time rather than sampled once. FSH is worth understanding beyond its role as a menopause marker: rising FSH has been associated with changes in blood pressure, triglycerides, and waist circumference.
Thyroid. This one gets missed often. Thyroid dysfunction produces fatigue, sleep disruption, weight change, mood changes, and menstrual irregularity, which is very nearly the perimenopause symptom list. Thyroid risk also rises with age, so the two frequently overlap. A TSH alone is a thin evaluation when symptoms persist. A fuller panel adds free T4 and free T3, with TPO and thyroglobulin antibodies where there is family or autoimmune history.
Metabolic. Fasting glucose is standard and insufficient on its own. Fasting insulin is ordered less often and is frequently more informative, because insulin can be climbing while glucose still reads normal. Paired with HbA1c, it gives a considerably earlier picture of insulin resistance, at a point where nutrition and activity changes still have real leverage.
Cardiovascular. Estrogen has a protective cardiovascular role, and that protection diminishes through the transition. A basic lipid panel is a starting point. ApoB better reflects the number of atherogenic particles, Lp(a) identifies inherited risk that standard panels miss, and hs-CRP and homocysteine add inflammation and vascular context.
Nutrients. Deficiencies amplify symptoms that are already present. Worth checking: 25-hydroxyvitamin D, iron and ferritin, magnesium, and an omega-3 index.
Bone. Bone loss is silent until a fracture. A DEXA scan is low-risk and quick, recommended at 65 and older, and earlier when risk factors are present.
Numbers are a guide, not the whole clinical picture. Treatment decisions should be driven by how you feel and how those symptoms track alongside your labs over time. Hormone therapy helps many women and is not appropriate for all of them, and that determination depends on age, personal and family risk, and where you are in the transition. It belongs in a conversation with a provider who knows your history, not in a general article.
The practical point is this: if you do not feel like yourself, “your labs are normal” is the beginning of the workup, not the end of it. Ask what was actually tested. If the answer is a TSH and a basic panel, there is more worth looking at.
If you would like to review comprehensive testing options, our team is glad to walk through what makes sense for your history and symptoms.
Source: Life Extension Wellness
